|
Immunological evaluation of NDI patients |
|||||
| III-3 32 yr |
III-4 29 yr |
IV-4 5 yr |
Normal range (adult) |
Normal range (children) |
|
|
|
|||||
| CD3+ [%] |
74.3 |
68.9 |
85.9 |
55–78 |
55–83 |
| CD4+/CD3+ [%] |
54.9 |
17.7 |
69.6 |
28–57 |
27–53 |
| CD8+/CD3+ [%] |
34.5 |
61.8 |
14 |
10–39 |
19–34 |
| CD4/CD8 |
1.6 |
0.3 |
5 |
1.0–3.6 |
0.9–2.6 |
| CD19+ [%] |
5.2 |
5.7 |
6.7 |
6–19 |
10–31 |
|
|
|||||
| IgG (mg/dl) |
810.0 |
741.0 |
754.0 |
870–1700 |
600–1450 |
| IgA (mg/dl) |
147.0 |
72.0 |
105.0 |
110–410 |
39–233 |
| IgM (mg/dl) |
59.0 |
127.0 |
72.0 |
33–190 |
69–268 |
|
|
|||||
| TREC/μgDNA |
1.9 × 102 |
2.8 × 102 |
1.6 × 103 |
3.4 ± 3.6 × 102 |
3.5 ± 2.8 × 103 |
|
The normal range of the lymphocyte subpopulation was lower and the upper confidence limit at a confidence level of 0.95. The normal range of IgG, IgA, and IgM are calculated as mean - 2SD (lower) and mean + 2SD (upper). The normal range of TREC is expressed as mean ± SD. | |||||
Fujimoto et al. BMC Medical Genetics 2008 9:42 doi:10.1186/1471-2350-9-42 |
|||||